0001562180-22-006026.txt : 20220810
0001562180-22-006026.hdr.sgml : 20220810
20220810174145
ACCESSION NUMBER: 0001562180-22-006026
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20220808
FILED AS OF DATE: 20220810
DATE AS OF CHANGE: 20220810
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Donovan Joanne M.
CENTRAL INDEX KEY: 0001644087
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40236
FILM NUMBER: 221152935
MAIL ADDRESS:
STREET 1: C/O CATABASIS PHARMACEUTICALS, INC.
STREET 2: ONE KENDALL SQ. BLDG. 1400E SUITE B14202
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Edgewise Therapeutics, Inc.
CENTRAL INDEX KEY: 0001710072
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 821725586
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3415 COLORADO AVE.
CITY: BOULDER
STATE: CO
ZIP: 80303
BUSINESS PHONE: 303-735-8373
MAIL ADDRESS:
STREET 1: 3415 COLORADO AVE.
CITY: BOULDER
STATE: CO
ZIP: 80303
4
1
primarydocument.xml
PRIMARY DOCUMENT
X0306
4
2022-08-08
false
0001710072
Edgewise Therapeutics, Inc.
EWTX
0001644087
Donovan Joanne M.
C/O EDGEWISE THERAPEUTICS, INC.
3145 COLORADO AVE
BOULDER
CO
80303
false
true
false
false
CMO
Stock Option (Right to Buy)
10.39
2022-08-08
4
A
false
240000.00
0.00
A
2032-08-08
Common Stock
240000.00
240000.00
D
1/48th of the shares subject to the option vest each month beginning on September 8, 2022, subject to the Reporting Person continuing as a service provider through each vest date.
John R. Moore Attorney-in-Fact for Donovan Joanne M.
2022-08-10
EX-24
2
donovan-poa.txt
POWER OF ATTORNEY
POWER OF ATTORNEY
The undersigned, as a Section 16 reporting person of Edgewise Therapeutics,
Inc. (the
"Company"), hereby constitutes and appoints Kevin Koch, Ph.D., R. Michael
Carruthers and
John R. Moore, and each of them, as the undersigned's true and lawful
attorney-in-fact to:
1. complete and execute Forms 3, 4 and 5 and other forms and all amendments
thereto as such attorney-in-fact shall in his discretion determine to be
required or
advisable pursuant to Section 16 of the Securities Exchange Act of 1934 (as
amended) and the rules and regulations promulgated thereunder, or any
successor
laws and regulations, as a consequence of the undersigned's ownership,
acquisition or disposition of securities of the Company; and
2. do all acts necessary in order to file such forms with the SEC, any
securities
exchange or national association, the Company and such other person or agency
as the attorneys-in-fact shall deem appropriate.
The undersigned hereby ratifies and confirms all that said attorneys-in-fact
and agents
shall do or cause to be done by virtue hereof. The undersigned acknowledges
that the foregoing
attorneys-in-fact, in serving in such capacity at the request of the
undersigned, are not assuming,
nor is the Company assuming, any of the undersigned's responsibilities to
comply with
Section 16 of the Securities Exchange Act of 1934 (as amended).
This Power of Attorney shall remain in full force and effect until the
undersigned is no
longer required to file Forms 3, 4 and 5 with respect to the undersigned's
holdings of and
transactions in securities issued by the Company, unless earlier revoked by
the undersigned in a
signed writing delivered to the Company and the foregoing attorneys-in-fact.
IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney
to be
executed as of this 3rd day of May, 2021.
/s/ Joanne M Donovan